Progress and Innovation in Japanese Encephalitis Vaccines: Toward Global Immunization

Area of Science:

• Public Health
• Virology
• Vaccinology

Background:

• Japanese encephalitis (JE) poses a significant global health threat, particularly in Asia and the Western Pacific, affecting over 3 billion people.
• JE's impact extends to economic development, influenced by healthcare, surveillance, and agricultural factors.
• Current JE vaccines, mainly targeting genotype III, show potential limitations as genotype I becomes dominant, raising concerns about efficacy.

Purpose of the Study:

• To review the progress and challenges in Japanese encephalitis vaccine development.
• To highlight emerging strategies and innovations for JE prevention.
• To emphasize the need for global protection against JE.

Main Methods:

• Literature review of JE epidemiology, vaccine development, and global health initiatives.
• Analysis of factors influencing JE disease patterns and vaccine efficacy.
• Examination of recent innovations in vaccine technology.

Main Results:

• Viral strain diversity and limited cross-protection challenge current JE vaccine effectiveness.
• Barriers to vaccine access include cold chain requirements, high costs, and the need for booster doses.
• Emerging innovations like thermostable, multivalent, and mRNA vaccines offer promising JE prevention solutions.

Conclusions:

• Despite progress, gaps in JE immunization coverage persist, necessitating innovative vaccine approaches.
• Global collaboration is vital for enhancing vaccine accessibility and achieving universal JE protection.
• Continued research and development are essential to combat the evolving threat of Japanese encephalitis.